PHARMAUST LIMITED
PAA - Awarded NZ$715k for Specialist GMP Peptide Capabilities - Dr Nick Hagen, CEO of Mimotopes
Fri, 1 Jun 2007 04:00PM
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Mr Simon Owen
Fri, 1 Jun 2007
04:00PM Australia/NSW
Select a tab above to display more information
PHARMAUST LIMITED (PAA)
ASX code: PAA
Website: http://www.pharmaust.com/
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
To develop a vertically integrated pharmaceutical company with expertise in high value drug discovery and drug production.
Address:
, , 50 Derby Road,
SUBIACO
WA
Phone: 08 9380 6550
Fax: 08 9380 4056
Executives & Directors
Mr Bryant McLarty , Executive Chairman
Mr Henry Gulev , Non Exec. Director
Mr Sam Wright , Non Exec. Director
Mr Sam Wright , Company Secretary
Company Podcasts
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
PHARMAUST LIMITED (PAA) Events
PHARMAUST LIMITED (PAA)
| Change of Director`s Interest Notice | Tue, 30 Jun 2009 |
| Change in substantial holding | Thu, 25 Jun 2009 |
| Change in substantial holding | Thu, 18 Jun 2009 |
| Appendix 4C - quarterly | Thu, 30 Apr 2009 |
| Becoming a substantial holder | Wed, 25 Mar 2009 |
| Change in substantial holding | Mon, 16 Mar 2009 |
| Section 708A Notice | Tue, 10 Mar 2009 |
| Share Placement Completion | Tue, 10 Mar 2009 |
| Appendix 3B | Tue, 10 Mar 2009 |
| Half Yearly Report and Accounts | Fri, 27 Feb 2009 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.






















